Anti-epileptic Drugs

Journal of Pain and Symptom Management

Volumn 42, Issue 5, 2011, Pages 788-804

  Howard, Paul ^a   Twycross, Robert ^b   Shuster, John ^c   Mihalyo, Mary ^d   Rémi, Jan ^e   Wilcock, Andrew ^f  

^a Duchess of Kent House   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c VANDERBILT UNIVERSITY   (United States)

^d DUQUESNE UNIVERSITY   (United States)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; DILTIAZEM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; FLECAINIDE; FLUPIRTINE; FOSPHENYTOIN SODIUM; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; LIDOCAINE; NIFEDIPINE; OPIATE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; TIAGABINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VERAPAMIL; VIGABATRIN; ZONISAMIDE;

ACNE; AGGRESSION; AGITATION; AGRANULOCYTOSIS; APLASTIC ANEMIA; ATAXIA; ATRIOVENTRICULAR BLOCK; BEHAVIOR DISORDER; BONE MARROW SUPPRESSION; BRAIN TUMOR; COARSE FACE; COGNITIVE DEFECT; DIPLOPIA; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG DOSE TITRATION; DRUG ELIMINATION; DRUG ERUPTION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG MONITORING; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; EPILEPTIC STATE; FLUID RETENTION; FOLIC ACID DEFICIENCY; GINGIVA HYPERTROPHY; HICCUP; HIRSUTISM; HOT FLUSH; HUMAN; HYPERAMMONEMIA; KIDNEY DISEASE; LIVER DISEASE; LIVER FAILURE; MANIA; MEMBRANE STABILIZATION; NEUROPATHIC PAIN; NEUROTRANSMITTER RELEASE; PALLIATIVE THERAPY; PANCREATITIS; PERSONALITY DISORDER; PHARMACOGENETICS; PRURITUS; RESTLESS LEGS SYNDROME; REVIEW; SEIZURE; SIDE EFFECT; SPASTICITY; STEVENS JOHNSON SYNDROME; SUICIDAL IDEATION; SUICIDE; TERATOGENICITY; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT INDICATION; TRIGEMINUS NEURALGIA; UROLITHIASIS; VISUAL FIELD DEFECT; VOMITING;

EID: 80155161306     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2011.10.007     Document Type: Short Survey

References (145)

1. E. Perucca An introduction to antiepileptic drugs Epilepsia 46 suppl 4 2005 31 37 (Pubitemid 40847381)
2. B.A. Lynch, N. Lambeng, and K. Nocka The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam Proc Natl Acad Sci U S A 101 26 2004 9861 9866 (Pubitemid 38869327)
3. V. Jevtovic-Todorovic, and S.M. Todorovic The role of peripheral T-type calcium channels in pain transmission Cell Calcium 40 2006 197 203 (Pubitemid 43942301)
4. A.A. Kochegarov Pharmacological modulators of voltage-gated calcium channels and their therapeutical application Cell Calcium 33 2003 145 162 (Pubitemid 36336303)
5. H.S. Shin T-type Ca2+ channels and absence epilepsy Cell Calcium 40 2006 191 196
6. W. Loscher Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy CNS Drugs 16 2002 669 694 (Pubitemid 35176853)
7. C.H. Lee, T.S. Tsai, and H.H. Liou Gabapentin activates ROMK1 channels by a protein kinase A (PKA)-dependent mechanism Br J Pharmacol 154 2008 216 225
8. P.L. Sheets, C. Heers, T. Stoehr, and T.R. Cummins Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine J Pharmacol Exp Ther 326 2008 89 99 (Pubitemid 351872141)
9. J. Devulder Flupirtine in pain management: pharmacological properties and clinical use CNS Drugs 24 2010 867 881
10. M. Devor Sodium channels and mechanisms of neuropathic pain J Pain 7 2006 S3 S12
11. P.J. Wiffen, S. Derry, R.A. Moore, and H.J. McQuay Carbamazepine for acute and chronic pain in adults Cochrane Database Syst Rev 1 2011 CD005451
12. V. Challapalli, I.W. Tremont-Lukats, E.D. McNicol, J. Lau, and D.B. Carr Systemic administration of local anesthetic agents to relieve neuropathic pain Cochrane Database Syst Rev 4 2005 CD003345
13. C.F. von Gunten, S. Eappen, and J.F. Cleary Flecainide for the treatment of chronic neuropathic pain: a Phase II trial Palliat Med 21 2007 667 672
14. C.P. Taylor Mechanisms of analgesia by gabapentin and pregabalin-calcium channel alpha2-delta [Cavalpha2-delta] ligands Pain 142 2009 13 16
15. C.S. Bauer, A. Tran-Van-Minh, I. Kadurin, and A.C. Dolphin A new look at calcium channel alpha2delta subunits Curr Opin Neurobiol 20 2010 563 571
16. L.A. Bee, and A.H. Dickenson Descending facilitation from the brainstem determines behavioural and neuronal hypersensitivity following nerve injury and efficacy of pregabalin Pain 140 2008 209 223
17. K. Hayashida, H. Obata, K. Nakajima, and J.C. Eisenach Gabapentin acts within the locus coeruleus to alleviate neuropathic pain Anesthesiology 109 2008 1077 1084
18. A. Boroujerdi, H.K. Kim, and Y.S. Lyu Injury discharges regulate calcium channel alpha-2-delta-1 subunit upregulation in the dorsal horn that contributes to initiation of neuropathic pain Pain 139 2008 358 366
19. S.G. Lu, X.L. Zhang, Z.D. Luo, and M.S. Gold Persistent inflammation alters the density and distribution of voltage activated calcium channels in subpopulations of rat cutaneous DRG neurons Pain 151 2010 633 643
20. R.H. Yang, W.T. Wang, J.Y. Chen, R.G. Xie, and S.J. Hu Gabapentin selectively reduces persistent sodium current in injured type-A dorsal root ganglion neurons Pain 143 2009 48 55
21. R.M. Kaminskia, A. Matagnea, and K. Leclercqa SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy Neuropharmacology 54 4 2008 715 720
22. R.G. Twycross, and A. Wilcock Hospice and palliative care formulary USA 2nd ed. 2008 Palliativedrugs.com Ltd. Nottingham 493 496
23. T. Takahashi, Y. Aoki, and K. Okubo Upregulation of Ca(v)3.2 T-type calcium channels targeted by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain Pain 150 2010 183 191
24. M.W. Mann, and G. Pons Various pharmacogenetic aspects of antiepileptic drug therapy: a review CNS Drugs 21 2007 143 164
25. W. Löscher, U. Klotz, F. Zimprich, and D. Schmidt The clinical impact of pharmacogenetics on the treatment of epilepsy Epilepsia 50 2009 1 23
26. T. Abe, T. Seo, and T. Ishitsu Association between SCN1A polymorphism and carbamazepine-resistant epilepsy Br J Clin Pharmacol 66 2008 304 307
27. T.R. Cummins, P.L. Sheets, and S.G. Waxman The roles of sodium channels in nociception: Implications for mechanisms of pain Pain 131 2007 243 257 (Pubitemid 47374344)
28. P.L. Sheets, J.O. Jackson 2nd, S.G. Waxman, S.D. Dib-Hajj, and T.R. Cummins A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity J Physiol 581 2007 1019 1031 (Pubitemid 46887978)
29. E. Perucca Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age Clin Pharmacokinet 45 2006 351 363
30. E. Perucca The clinical pharmacokinetics of the new antiepileptic drugs Epilepsia 40 Suppl 9 1999 S7 13
31. W.R. Garnett Clinical pharmacology of topiramate: a review Epilepsia 41 Suppl 1 2000 S61 S65
32. th ed. 2002 McGraw Hill New York
33. E. Perucca Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience CNS Drugs 16 2002 695 714 (Pubitemid 35176854)
34. T.W. May, E. Korn-Merker, and B. Rambeck Clinical pharmacokinetics of oxcarbazepine Clin Pharmacokinet 42 2003 1023 1042 (Pubitemid 37186675)
35. L.M. Bang, and K.L. Goa Spotlight on oxcarbazepine in epilepsy CNS Drugs 18 2004 57 61
36. P. Kwan, and M.J. Brodie Phenobarbital for the treatment of epilepsy in the 21st century: a critical review Epilepsia 45 2004 1141 1149 (Pubitemid 39238126)
37. P.N. Patsalos Clinical pharmacokinetics of levetiracetam Clin Pharmacokinet 43 2004 707 724 (Pubitemid 39159001)
38. W.H. Chung, S.I. Hung, and H.S. Hong Medical genetics: a marker for Stevens-Johnson syndrome Nature 428 2004 486
39. C. Locharernkul, J. Loplumlert, and C. Limotai Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B1502 allele in Thai population Epilepsia 49 2008 2087 2091
40. U.S. Food and Drug Administration. Dangerous or even fatal skin reactions - carbamazepine (marketed as Carbatrol, Equetro, Tegretol and generics). 2007. Available from http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm124718.htm. Accessed October 12, 2011.
41. U.S. Food and Drug Administration. Phenytoin (marketed as Dilantin, Phenytek and generics) and fosphenytoin (marketed as Cerebyx and generics). 2008. Available from http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm124788.htm. Accessed October 12, 2011.
42. R.G. Twycross, and A. Wilcock Palliative care formulary 4th ed. 2011 Palliativedrugs.com Ltd. Nottingham 659 663
43. L.J. Hirsch, H. Arif, and E.A. Nahm Cross-sensitivity of skin rashes with antiepileptic drug use Neurology 71 2008 1527 1534
44. D.J. Morgan, and A.J. McLean Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update Clin Pharmacokinet 29 1995 370 391
45. S. Ford-Dunn Managing patients with cancer and advanced liver disease Palliat Med 19 2005 563 565 (Pubitemid 41645516)
46. M. Bagary (2011) Epilepsy, antiepileptic drugs and suicidality Curr Opin Neurol 24 2011 177 182
47. U.S. Food and Drug Administration. Safety information. Antiepileptic drugs. 2008. Available from www.fda.gov/Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ucm074939.htm. Accessed October 12, 2011.
48. European Medicines Agency. Meeting highlights from the Committee for Medicinal Products for Human Use, 15-18 December 2008. Available from www.emea.europa.eu/pdfs/human/press/pr/67072408en.pdf. Accessed October 12, 2011.
49. A.G. Marson, A.M. Al-Kharusi, and M. Alwaidh The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial Lancet 369 2007 1016 1026 (Pubitemid 46436125)
50. A.G. Marson, A.M. Al-Kharusi, and M. Alwaidh The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial Lancet 369 2007 1000 1015 (Pubitemid 46436124)
51. P. Kwan, and M.J. Brodie Neuropsychological effects of epilepsy and antiepileptic drugs Lancet 357 2001 216 222 (Pubitemid 32108114)
52. V. Dinkelacker, T. Dietl, G. Widman, U. Lengler, and C.E. Elger Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases Epilepsy Behav 4 2003 537 547 (Pubitemid 37407612)
53. D. Weintraub, R. Buchsbaum, S.R. Resor Jr., and L.J. Hirsch Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy Epilepsy Behav 10 2007 105 110 (Pubitemid 46132156)
54. J.R. White, T.S. Walczak, and I.E. Leppik Discontinuation of levetiracetam because of behavioral side effects: a case-control study Neurology 61 2003 1218 1221 (Pubitemid 37377540)
55. P. Major, E. Greenberg, A. Khan, and E.A. Thiele Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary results Epilepsy Behav 13 2008 557 559
56. G.P. Davis, J.T. McCarthy, D.B. Magill, and B. Coffey Behavioral effects of levetiracetam mitigated by pyridoxine J Child Adolesc Psychopharmacol 19 2009 209 211
57. J.A. French First-choice drug for newly diagnosed epilepsy. [comment] Lancet 369 2007 970 971 (Pubitemid 46436134)
58. E. Perucca, L. Gram, G. Avanzini, and O. Dulac Antiepileptic drugs as a cause of worsening seizures Epilepsia 39 1998 5 17 (Pubitemid 28116836)
59. N.B. Finnerup, S.H. Sindrup, and T.S. Jensen The evidence for pharmaceutical treatment of neuropathic pain Pain 150 2010 573 581
60. T. Saarto, and P.J. Wiffen (2007) Antidepressants for neuropathic pain Cochrane Database Syst Rev 4 2007 Oct 17 CD005454 [update of Cochrane Database Syst Rev 2005;(3):CD005454]
61. R.H. Dworkin, A.B. O'Connor, and J. Audette Recommendations for the pharmacological management of neuropathic pain: an overview and literature update Mayo Clin Proc 85 2010 S3 S14
62. N. Attal, G. Cruccu, and R. Baron EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision Eur J Neurol 17 2010 e1113 e1188
63. A. Caraceni, E. Zecca, and C. Bonezzi Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group J Clin Oncol 22 2004 2909 2917 (Pubitemid 41079911)
64. M.I. Bennett Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review Palliat Med 25 2011 553 559
65. C.K. Pandey, M. Raza, and M. Tripathi The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barre syndrome patients in the intensive care unit Anesth Analg 101 2005 220 225 (Pubitemid 40853379)
66. J.R. Hardy, E.A. Rees, and B. Gwilliam A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain J Pain Symptom Manage 21 2001 204 209 (Pubitemid 32194417)
67. A.J. Snare Sodium valproate. Retrospective analysis of neuropathic pain control in patients with advanced cancer J Pharm Tech 9 1993 114 117 (Pubitemid 23199460)
68. D.K. Kochar, N. Jain, and R.P. Agarwal Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study Acta Neurol Scand 106 2002 248 252 (Pubitemid 35177990)
69. D.K. Kochar, N. Rawat, and R.P. Agrawal Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study QJM 97 2004 33 38 (Pubitemid 38195700)
70. D.K. Kochar, P. Garg, and R.A. Bumb Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study QJM 98 2005 29 34
71. M. Otto, F.W. Bach, T.S. Jensen, and S.H. Sindrup Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial Neurology 62 2004 285 288 (Pubitemid 38167141)
72. R.W. Richter, R. Portenoy, and U. Sharma Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial J Pain 6 2005 253 260 (Pubitemid 40488803)
73. J. Rosenstock, M. Tuchman, L. LaMoreaux, and U. Sharma Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial Pain 110 2004 628 638 (Pubitemid 39036794)
74. T. Tölle, R. Freynhagen, M. Versavel, U. Trostmann, and J.P. Young Jr. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study Eur J Pain 12 2008 203 213 (Pubitemid 350180540)
75. R. Freynhagen, K. Strojek, T. Griesing, E. Whalen, and M. Balkenohl Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens Pain 115 2005 254 263 (Pubitemid 40725282)
76. R. Sabatowski, R. Gálvez, and D.A. Cherry Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial Pain 109 2004 26 35 (Pubitemid 38479767)
77. R. van Seventer, H.A. Feister, and J.P. Young Jr. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial Curr Med Res Opin 22 2006 375 384 (Pubitemid 44296762)
78. R.H. Dworkin, A.E. Corbin, and J.P. Young Jr. (2003) Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial Neurology 60 2003 1274 1283 (Pubitemid 36460982)
79. P.J. Wiffen, S. Derry, R.A. Moore, and H.J. McQuay Carbamazepine for acute and chronic pain Cochrane Database Syst Rev 3 2005 Jul 20 CD005451
80. G. McCleane Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study Anesth Analg 89 1999 985 988 (Pubitemid 29458478)
81. M. Swerdlow, and J. Cundill Anticonvulsant drugs used in the treatment of lancinating pain: a comparison Anaesthesia 36 1981 1129 1132 (Pubitemid 12203199)
82. A.J. Bouckoms, and R.E. Litman Clonazepam in the treatment of neuralgic pain syndrome Psychosomatics 26 1985 933 936 (Pubitemid 16176784)
83. S.L. Bartusch, B.J. Sanders, J.G. D'Alessio, and J.R. Jernigan Clonazepam for the treatment of lancinating phantom limb pain Clin J Pain 12 1996 59 62 (Pubitemid 26128588)
84. H. Hugel, J.E. Ellershaw, and A. Dickman Clonazepam as an adjuvant analgesic in patients with cancer-related neuropathic pain J Pain Symptom Manage 26 2003 1073 1074 (Pubitemid 37488014)
85. C.M. Morello, S.G. Leckband, C.P. Stoner, D.F. Moorhouse, and G.A. Sahagian Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain Arch Intern Med 159 1999 1931 1937 (Pubitemid 29424714)
86. K. Chandra, N. Shafiq, P. Pandhi, S. Gupta, and S. Malhotra Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial - the GONIP Trial Int J Clin Pharmacol Ther 44 2006 358 363 (Pubitemid 44210010)
87. I. Gilron, J.M. Bailey, and D. Tu Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial Lancet 374 2009 1252 1261
88. S.N. Raja, J.A. Haythornthwaite, and M. Pappagallo Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial Neurology 59 2002 1015 1021
89. I. Gilron, J.M. Bailey, and D. Tu Morphine, gabapentin, or their combination for neuropathic pain N Engl J Med 352 2005 1324 1334 (Pubitemid 40411499)
90. K. Keskinbora, A.F. Pekel, and I. Aydinli Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial J Pain Symptom Manage 34 2007 183 189 (Pubitemid 47088905)
91. C. Solaro, and M. Messmer Uccelli Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis Eur Neurol 44 2000 45 48 (Pubitemid 30456792)
92. L.C. Miller, and F.W. Drislane Treatment strategies after a single seizure: rationale for immediate versus deferred treatment CNS Drugs 21 2007 89 99
93. R. Rud, E. Trevisan, and R. Soffietti Epilepsy and brain tumors Curr Opin Oncol 22 2010 611 620
94. B. Schaller Brain tumor and seizures: pathophysiology and its implications for treatment revisited (Epilepsia 2003;44:1223-1232) Epilepsia 47 2006 661 author reply 661 (Pubitemid 43351576)
95. C.J. Vecht, and M. van Breemen Optimizing therapy of seizures in patients with brain tumours Neurology 67 2006 S10 S13
96. M.S. van Breemen, E.B. Wilms, and C.J. Vecht Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management Lancet Neurol 6 2007 421 430 (Pubitemid 46551867)
97. M.S. van Breemen, R.M. Rijsman, and M.J. Taphoorn Efficacy of anti-epileptic drugs in patients with gliomas and seizures J Neurol 256 2009 1519 1526
98. E. Perucca, and P. Kwan Overtreatment in epilepsy: how it occurs and how it can be avoided CNS Drugs 19 2005 897 908 (Pubitemid 41571990)
99. P. Kwan, and M.J. Brodie Effectiveness of first antiepileptic drug Epilepsia 42 2001 1255 1260 (Pubitemid 33070664)
100. O. Kargiotis, S. Markoula, and A.P. Kyritsis Epilepsy in the cancer patient Cancer Chemother Pharmacol 67 2011 489 501
101. M.M. Ward, N.M. Barbaro, K.D. Laxer, and I.J. Rampil Preoperative valproate administration does not increase blood loss during temporal lobectomy Epilepsia 37 1996 98 101 (Pubitemid 26021584)
102. G.D. Anderson, Y.X. Lin, C. Berge, and G.A. Ojemann Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment J Neurosurg 87 1997 252 256 (Pubitemid 27349110)
103. National Institute for Health and Clinical Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. 2004. Available from www.nice.org.uk/nicemedia/pdf/ CG020fullguideline.pdf. Accessed October 12, 2011.
104. S. Karceski, M.J. Morrell, and D. Carpenter Treatment of epilepsy in adults: expert opinion, 2005 Epilepsy Behav 7 Suppl 1 2005 S1 S64 quiz S65-67
105. L.J. Stephen, and M.J. Brodie Seizure freedom with more than one antiepileptic drug Seizure 11 2002 349 351 (Pubitemid 35154146)
106. C.L. Deckers, S.J. Czuczwar, and Y.A. Hekster Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed Epilepsia 41 2000 1364 1374
107. M.J. Glantz, B.F. Cole, and P.A. Forsyth Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 54 2000 1886 1893 (Pubitemid 30327107)
108. National Institute for Health and Clinical Excellence. Clinical Guideline 20. Epilepsy in adults and children: full guideline. Appendix C: Guidelines for treating status epilepticus in adults and children. 2010. Available from http://www.nice.org.uk/nicemedia/live/10954/29536/29536.pdf. Accessed October 12, 2011.
109. K. Prasad, K. Al-Roomi, P.R. Krishnan, and R. Sequeira Anticonvulsant therapy for status epilepticus Cochrane Database Syst Rev 4 2005 CD003723
110. F.E. Dreifuss, N.P. Rosman, and J.C. Cloyd A comparison of rectal diazepam gel and placebo for acute repetitive seizures N Engl J Med 338 1998 1869 1875 (Pubitemid 28287858)
111. S. Shorvon The treatment of status epilepticus Curr Opin Neurol 24 2011 165 170
112. R. Twycross, A. Wilcock, and C. Stark Toller Symptom management in advanced cancer 4th ed. 2009 palliativedrugs.com Nottingham 283-284
113. S. Lorenzl, S. Mayer, and B. Feddersen Nonconvulsive status epilepticus in palliative care patients J Pain Symptom Manage 40 2010 460 465
114. R. Twycross, A. Wilcock, and C. Stark Toller Symptom management in advanced cancer 4th ed. 2009 palliativedrugs.com Nottingham 430-433
115. National Institute for Health and Clinical Excellence. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. Clinical guideline CG38. 2006. Available from www.nice.org.uk/CG38. Accessed October 12, 2011.
116. A. Yildiz, E. Vieta, S. Leucht, and R.J. Baldessarini Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials Neuropsychopharmacology 36 2011 375 389
117. M. Van Ameringen, C. Mancini, B. Pipe, and M. Bennett Antiepileptic drugs in the treatment of anxiety disorders: role in therapy Drugs 64 2004 2199 2220 (Pubitemid 39382209)
118. J.E. Frampton, and R.H. Foster Pregabalin: in the treatment of generalised anxiety disorder CNS Drugs 20 2006 685 693 discussion 694-695. [erratum appears in CNS Drugs. 2007;21(6):481] (Pubitemid 44141496)
119. A.C. Pande, D.E. Feltner, and J.W. Jefferson Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study J Clin Psychopharmacol 24 2004 141 149 (Pubitemid 38380837)
120. A.C. Pande, J.R. Davidson, and J.W. Jefferson Treatment of social phobia with gabapentin: a placebo-controlled study J Clin Psychopharmacol 19 1999 341 348 (Pubitemid 29344848)
121. A.C. Pande, M.H. Pollack, and J. Crockatt Placebo-controlled study of gabapentin treatment of panic disorder J Clin Psychopharmacol 20 2000 467 471 (Pubitemid 30463763)
122. M.H. Pollack, P.P. Roy-Byrne, and M. Van Ameringen The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study J Clin Psychiatry 66 2005 1401 1408 (Pubitemid 41779538)
123. M.A. Hertzberg, M.I. Butterfield, and M.E. Feldman A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder Biol Psychiatry 45 1999 1226 1229 (Pubitemid 29236566)
124. D. Baldwin, R. Woods, R. Lawson, and D. Taylor Efficacy of drug treatments for generalised anxiety disorder: systemic review and meta-analysis BMJ 342 2011 1199
125. K.J. Pandya, G.R. Morrow, and J.A. Roscoe (2005) Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial Lancet 366 2005 818 824 (Pubitemid 41557381)
126. H.D. Nelson, K.K. Vesco, and E. Haney (2006) Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis JAMA 295 2006 2057 2071 (Pubitemid 44794007)
127. L. Bordeleau, K.I. Pritchard, and C.L. Loprinzi Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors J Clin Oncol 28 2010 5147 5152
128. G. Porzio, F. Aielli, and L. Verna Gabapentin in the treatment of severe sweating experienced by advanced cancer patients Support Care Cancer 14 2006 389 391
129. H. Alonso-Navarro, L. Rubio, and F.J. Jiménez-Jiménez Refractory hiccup: successful treatment with gabapentin Clin Neuropharmacol 30 2007 186 187 (Pubitemid 46871868)
130. A. Jatzko, A. Stegmeier-Petroianu, and G.A. Petroianu Alpha-2-delta ligands for singultus (hiccup) treatment: three case reports J Pain Symptom Manage 33 2007 756 760 (Pubitemid 46783989)
131. R. Moretti, P. Torre, and R.M. Antonello (2004) Gabapentin as a drug therapy of intractable hiccup because of vascular lesion: a three-year follow up Neurologist 10 2004 102 106 (Pubitemid 38365484)
132. Earley CJ, Allen RP, Hening W. (2011) Restless legs syndrome and periodic leg movements in sleep. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. 2011;99:913-948.
133. R.K. Bogan, M.A. Bornemann, and C.A. Kushida (2010) Long-term maintenance treatment of restless legs syndrome with gabapentin enacarbil: a randomized controlled study Mayo Clin Proc 85 2010 512 521
134. D. Garcia-Borreguero, O. Larrosa, and A.M. Williams Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study Neurology 74 2010 1897 1904
135. R. Allen, C. Chen, and A. Soaita A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome Sleep Med 11 2010 512 519
136. S. Happe, C. Sauter, G. Klösch, B. Saletu, and J. Zeitlhofer Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome Neuropsychobiology 48 2003 82 86 (Pubitemid 37176872)
137. C. Trenkwalder, W.A. Hening, and P. Montagna Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice Mov Disord 23 2008 2267 2302
138. V.L. Stevenson Rehabilitation in practice: spasticity management Clin Rehabil 24 2010 293 304
139. Z. Zylicz, R. Twycross, and E.A. Jones Pruritus in advanced disease 2004 Oxford University Press Oxford
140. L. Manenti, P. Tansinda, and A. Vaglio Uraemic pruritus: clinical characteristics, pathophysiology and treatment Drugs 69 2009 251 263
141. J. Kanitakis Brachioradial pruritus: report of a new case responding to gabapentin Eur J Dermatol 16 2006 311 312 (Pubitemid 43736159)
142. P.D. Yesudian, and N.J. Wilson Efficacy of gabapentin in the management of pruritus of unknown origin Arch Dermatol 141 2005 1507 1509 (Pubitemid 41819025)
143. L.N. Ranganathan, and S. Ramaratnam Rapid versus slow withdrawal of antiepileptic drugs Cochrane Database Syst Rev 2 2006 CD005003
144. D. Chadwick The withdrawal of antiepileptic drugs A. Hopkins, S.D. Shorvon, G. Cascino, Epilepsy 2nd ed. 1995 Chapman and Hall London 215 220
145. A. Hopkins, and S. Shorvon (1995) Definitions and epidemiology of epilepsy A. Hopkins, S.D. Shorvon, G. Cascino, Epilepsy 2nd ed. 1995 Chapman and Hall London 1 24